BridgeMD
Tests treatment safety and results for Varicella (Chickenpox)
Official title A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
ClinicalTrials.gov ID: NCT07054099
What this study is testing
What is MG1111 (Barycela inj.)?
MG1111 (Barycela inj.) is an investigational medicine, being studied as a potential treatment for varicella (chickenpox).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical study aims to evaluate the safety and immune response of MG1111, in healthy children compared to VARIVAX. The study will follow participants for 42 days after receiving two doses, with additional follow-ups for up to 10 years to monitor varicella infection.
- Phase 3: a large, late-stage study
- Time commitment: about 10 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 12. Healthy volunteers may be eligible.
You may be able to join if
- Participant must be 12 months to 12 years of age, inclusive, at the time of signing the informed consent or assent.
- Participant is overtly healthy as determined by the investigator
You likely can't join if
- Participants with a history of exposure to varicella through contact with a varicella patient at home, school, or childcare facility within 4 weeks...
- Participants with a history of varicella infection and varicella vaccine, either licensed or investigational, and either standalone or any...
- Participants with acute moderate or severe infection with or without fever at the time of dosing
- Participants who have had any suspected allergy symptoms, such as systemic rash, during the 72 hours before each administration of investigational...
The study team makes the final eligibility decision.
Where it's taking place
- Khon Kaen, Changwat Khon Kaen, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 12 months to 12 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Khon Kaen, Changwat Khon Kaen, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.